The ’Life Sciences ‘Sector Deal’ was announced last week – the first in a string of ‘sector deals’, to be rolled out as part of the Government’s wider Industrial Strategy. The deal is a series of commitments and investments from both Government and industry, which take forward elements of the...
Morningside Pharmaceuticals sponsors special event at LOROS
Loughborough based pharmaceutical company, Morningside Pharmaceuticals Ltd, will be helping people remember a loved one this festive season by sponsoring a special event held at LOROS Hospice. Light up a Life will this year be taking place on Sunday 3rd December, an event which occurs every year giving people the...
Nemaura Pharma develops and trials new pain relief treatment
Nemaura Pharma, based on Loughborough University Science and Enterprise Park, has developed an efficient and cost-effective pain-relief system for sufferers of acute arthritic-related pain. The company has developed two new gels which, in laboratory, trials achieve up to three-times faster drug penetration rate and faster onset of action. They also...
Life-saving baby medical device is born out of East Midlands collaboration
Three companies who are members of Medilink East Midlands (EM) have joined together in the creation of an innovative baby health product that could save millions of lives. This is a result of the Medilink EM INSTILS support programme, which is part-funded by the European Regional Development Fund (ERDF). SurePulse...
200 jobs to be created as firm looks to expand
A pharmaceutical firm is set to create 200 jobs in Loughborough after passing a Government inspection. Almac Pharma Services, in Loughborough, has been given a licence by the UK Medicines and Healthcare products Regulatory Agency (MHRA) to begin production of certain kinds of drugs. The firm, which has research facilities...
Summary of the final Food Supplements Special Interest Group for 2017
The final Food Supplement Special Interest Group meeting of 2017, focussed on different aspects to consider when developing food supplements as liquid formulations. The scene was set in the morning by Janet Worrell (consult2deliver limited) with a look at the heritage of the original liquid food supplement, cod liver oil...
The BioCity UK Life Science Start-up Reports
The 2017 BioCity UK Life Science Start-up report has the benefit of 12 years of data on the creation and funding of life science companies. This data collection stemmed from a desire to better understand the market BioCity operates in as a life science incubator. It has now evolved into...
Nottingham-headquartered BioCity expands in Aberdeen
BioCity, the Nottingham headquartered life sciences incubation business, is set to further expand operations following its appointment to run a new bespoke accelerator programme in Aberdeen. The accelerator programme is being launched to catalyse growth in Aberdeen’s world-class life sciences cluster by supporting the development of start-ups, spin-outs and growth...
Notts drug development firm swoops for Reading counterpart
Quotient Sciences, the Ruddington drug development services organisation, has bought Pharmaterials, a contract development and manufacturing organisation (CDMO) based in Reading, for an undisclosed sum. The deal follows the acquisitions of SeaView Research and QS Pharma in February 2017. Pharmaterials has a significant track record in supporting the development of...
BPR Medical secures licence to sell life-saving oxygen firebreak in Japan
BPR Medical’s Firesafe™ cannula valve, which can prevent patient deaths and limit injuries in the event of an oxygen fire, has been licensed for use among Japan’s 160,000 home oxygen patients. Thousands of patients who rely on oxygen to alleviate the symptoms of respiratory diseases such as Chronic Obstructive Pulmonary...
